Business UpdateJun 4, 2026, 08:03 AM
Emergent BioSolutions Partners for Naloxone Awareness Day, Expands Access
AI Summary
Emergent BioSolutions is partnering with Victoria's Voice Foundation for National Naloxone Awareness Day on June 6th to combat the ongoing opioid epidemic. The collaboration supports the "Shine. Wear. Share. Care." campaign, which promotes education and preparedness by distributing purple light bulbs, promotional items, social media engagement, and NARCAN® Nasal Spray. Emergent is committed to expanding access to NARCAN® Nasal Spray, including through a new carrying case and the "Ready to Rescue" initiative with spokesperson Zac Clark. The company is a leading U.S. supplier of nasal naloxone, offering both OTC NARCAN® and prescription KLOXXADO®.
Key Highlights
- Emergent BioSolutions partners with Victoria’s Voice Foundation for National Naloxone Awareness Day on June 6th.
- Supports the "Shine. Wear. Share. Care." campaign to raise awareness and distribute NARCAN® Nasal Spray.
- Introduces a new compact, discreet, and durable NARCAN® Nasal Spray Carrying Case.
- Continues the "Ready to Rescue" initiative with spokesperson Zac Clark, expanding to colleges and universities.
- NARCAN® Nasal Spray 4 mg is the first FDA-approved over-the-counter opioid overdose reversal treatment.
- Emergent gained exclusive commercial rights to KLOXXADO® (naloxone HCl) Nasal Spray 8 mg in 2025.
- Emergent is the leading U.S. supplier of nasal naloxone, offering a range of products for various groups.
Price Impact
More from EBS